Paluratide (LUNA18) is a reversible cyclic peptide KRAS inhibitor with the advantages of oral availability and cell permeability for the treatment of kras-mutant cancers, which inhibits cancer cell proliferation by phosphorylating ERK and AKT, and also inhibits the interaction of RAS with guanine nucleotide exchange factors (GEFs).
Molecular Weight:
1437.68
Purity:
98.70%
CAS Number:
[2676177-63-0]
Formula:
C73H105F5N12O12
Target:
ERK|||Akt|||Ras|||Kras
T79673
T79673
* VAT and and shipping costs not included. Errors and price changes excepted